Fennec Pharmaceuticals Inc.FENCNASDAQ
Loading
Operating Income Growth AcceleratingAccelerating
Percentile Rank100
3Y CAGR+197.8%
Year-over-Year Change
Year-over-year operating income growth rate
3Y CAGR
+197.8%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
26.4x
Strong expansion
Streak
2 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2024 | 120.11% |
| 2023 | 41.13% |
| 2022 | -27.08% |
| 2021 | 4.55% |
| 2020 | -34.36% |
| 2019 | -27.88% |
| 2018 | -49.75% |
| 2017 | -142.11% |
| 2016 | -51.90% |
| 2015 | 34.31% |